Aktis Oncology, Inc. Common stock (AKTS) Stock Price, Quote & AI Analysis
Live AKTS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Aktis Oncology, Inc. Common stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Aktis Oncology, Inc. Common stock (AKTS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Aktis Oncology, Inc. Common stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Aktis Oncology, Inc. Common stock Overview
Company information
Company Overview
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Aktis Oncology, Inc. Common stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...